首页> 外文期刊>American journal of otolaryngology >Follicular dendritic cell tumor: an aggressive head and neck tumor.
【24h】

Follicular dendritic cell tumor: an aggressive head and neck tumor.

机译:滤泡性树突状细胞瘤:侵袭性头颈肿瘤。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

OBJECTIVE: To characterize the clinicopathologic features of head and neck follicular dendritic cell (FDC) tumor and report the experience of this entity at our institution. Study Design: Two case presentations are compared with a retrospective analysis of all published head and neck cases. SETTING: A tertiary academic medical center. RESULTS: Thirty four cases of FDC tumor of the head and neck cases have been published. Twenty five occurred in the cervical lymph nodes, 4 in the tonsils, 2 in the palate, 1 in the pharynx, 1 in the parapharyngeal region, and 1 in the thyroid gland. Patient ages ranged from 13 to 73 years (mean, 38), and there was a roughly equal number of men and women. Patients were treated with surgery (17), surgery and chemotherapy (8), and surgery and radiation (9). After the primary treatment, 12 patients had no evidence of disease, whereas 5 were incurable. Ten tumors recurred locally and 3 distally. Of these 13 patients who suffered recurrences, 4 had no evidence of disease after secondary treatment, 6 were alive with disease, and one was lost to follow up. Two patients died after recurrence. We add 2 unique cases to the 9 previously reported extranodal cases, 1 in the tonsil and 1 in the parotid gland. CONCLUSION: FDC tumor is a rare malignant neoplasm that can present in the head and neck region in both lymph nodes and extranodal sites. Because of their rarity, these tumors are probably underrecognized by both clinicians and pathologists. Distinct light microscopic, immunohistochemical, and ultrastructural features do exist, however, and are reviewed. Surgery has been the mainstay of treatment and should include diligent control of surgical margins. The role of adjuvant therapy remains controversial. Although originally considered to be a low-grade malignancy, our review suggests both high recurrence rates and metastatic potential. We believe that FDC tumor should be viewed and treated as a moderately aggressive head and neck tumor.
机译:目的:表征头颈部滤泡树突状细胞(FDC)肿瘤的临床病理特征,并报告该实体在我院的经验。研究设计:比较两个病例报告,并对所有已发表的头颈部病例进行回顾性分析。地点:三级学术医学中心。结果:已公布头颈部FDC肿瘤34例。颈部淋巴结肿大25例,扁桃体4例,上late 2例,咽部1例,咽旁区1例,甲状腺1例。患者年龄范围为13至73岁(平均38岁),男女人数大致相等。患者接受了外科手术(17),外科手术和化学疗法(8)以及外科手术和放射线(9)的治疗。初次治疗后,有12例患者无疾病迹象,而5例是无法治愈的。局部复发10例,远端复发3例。在这13例复发的患者中,有4例在二级治疗后无疾病迹象,有6例仍然活着,另有1例失访。两名患者在复发后死亡。我们在先前报告的9个结外病例中增加了2个独特病例,其中扁桃体1个,腮腺1个。结论:FDC肿瘤是一种罕见的恶性肿瘤,可存在于淋巴结和结外部位的头颈部区域。由于它们的稀有性,临床医生和病理学家都可能无法识别这些肿瘤。但是,确实存在不同的光学显微镜,免疫组织化学和超微结构特征,并进行了综述。手术一直是治疗的主要手段,应包括严格控制手术切缘。辅助治疗的作用仍存在争议。尽管最初被认为是低度恶性肿瘤,但我们的综述显示,高复发率和转移潜能都很高。我们认为,FDC肿瘤应被视为中度侵袭性头颈部肿瘤并进行治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号